Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonidamine for benign prostatic hyperplasia
NCT00237536Phase 2Terminated
- Sponsor
- Threshold Pharmaceuticals
- Start
- Jun 2005
- Primary completion
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Lonidamine with Placebo (2 arms). Primary endpoint: International Prostate Symptom Score. Started Jun 2005; status: terminated.
02
Drugs
lonidamine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00237536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00237536.